Long term use of heartburn drugs linked to fractures
FDA: Possible Fracture Risk with High Dose, Long-term Use of Proton Pump Inhibitors — Labeling changes will include new safety information – The U.S. Food and Drug Administration warned consumers and health care professionals about a possible increased risk of fractures of the hip, wrist, and spine with high doses or long-term use of a class of medications called proton pump inhibitors.